Inventor · disambiguated record
Clifford J. Whatcott
Also filed as: WHATCOTT CLIFFORD J
9 granted patents·6 pending applications·68 citations·filing 2016–2020
88Inventor score
Files withTOLERO PHARMACEUTICALS INC9SUMITOMO DAINIPPON PHARMA ONCOLOGY INC3SUMITOMO PHARMA ONCOLOGY INC2MAYO FOUND MEDICAL EDUCATION & RES1
Top patents by PatentIndex Score
15 records- 0196US10835537B2Combination therapies for treatment of cancerSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2020·Granted Nov 17, 2020·7 cites·6 claims
- 0296US10568887B2Combination therapies for treatment of cancerTOLERO PHARMACEUTICALS INC·Filed 2016·Granted Feb 25, 2020·10 cites·1 claims
- 0395US10267787B2Profiling peptides and methods for sensitivity profilingTOLERO PHARMACEUTICALS INC·Filed 2018·Granted Apr 23, 2019·13 cites·13 claims
- 0493US10132797B2Profiling peptides and methods for sensitivity profilingTOLERO PHARMACEUTICALS INC·Filed 2017·Granted Nov 20, 2018·15 cites·15 claims
- 0592US10422788B2Profiling peptides and methods for sensitivity profilingTOLERO PHARMACEUTICALS INC·Filed 2019·Granted Sep 24, 2019·11 cites·19 claims
- 0691US10682356B2Combination therapies for treatment of cancerTOLERO PHARMACEUTICALS INC·Filed 2019·Granted Jun 16, 2020·7 cites·1 claims
- 0790US11497756B2Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidibSUMITOMO PHARMA ONCOLOGY INC·Filed 2018·Granted Nov 15, 2022·4 cites·18 claims
- 0876US11040038B2Methods for treating diseases associated with abnormal ACVR1 expression and ACVR1 inhibitors for use in the sameSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2019·Granted Jun 22, 2021·1 cites·11 claims
- 0972US2020200737A1Profiling peptides and methods for sensitivity profilingTOLERO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1068US2021228582A1Combination therapies for treatment of cancerSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1166US2020276174A1Cyclin-dependent kinase inhibitors in combination with anthracyclines for treatment of cancerTOLERO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1263US2019314357A1Cyclin-dependent kinase inhibitors in combination with anthracyclines for treatment of cancerTOLERO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1352US11529350B2Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereofSUMITOMO PHARMA ONCOLOGY INC·Filed 2020·Granted Dec 20, 2022·0 cites·51 claims
- 1449US2021145830A1Materials and methods for treating cancerMAYO FOUND MEDICAL EDUCATION & RES·Filed 2019·Application pending·0 cites
- 1549US2020237766A1Pkm2 activators in combination with reactive oxygen species for treatment of cancerTOLERO PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Clifford J. Whatcott files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →